Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Verta receives grant for pilot HCV study of SCV-07

Aug. 30, 2004

XTL Biopharmaceuticals to enroll new patients in HepeX-C study

Aug. 30, 2004

FDA approves Zelnorm for chronic constipation

Aug. 25, 2004

New HGF modulators prepared and tested at Angion Biomedica

Aug. 23, 2004

Enrollment to resume in optional retreatment arm of phase I/II Nuvion study

Aug. 12, 2004

New formulation of Solon launched in Japan

Aug. 10, 2004

Targeting IP-10 for IBD: Protein Design Labs characterizes antibody for clinical development

Aug. 5, 2004

Remofovir mesylate enters phase II

Aug. 5, 2004

New benzimidazole-based gastric antisecretory agents claimed by Altana Pharma

Aug. 5, 2004

Merck KGaA describes new derivatives of the kappa opioid agonist asimadoline

Aug. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...